Abstract
This review aims to reflect upon the major developments in PARP14 research from late 2017 to early 2020. In doing so, this report will focus on the continual elucidation of PARP14's function including an emerging role in viral replication. This is in addition to other functional developments in cancer and inflammation, along with reflecting upon the leads in inhibitor design, including the increased attention toward the macrodomain. This report will also include a brief recap on contemporary poly(ADP-ribose) polymerase inhibitors and reflect upon the development surrounding the other poly(ADP-ribose) polymerases to overall give a succinct update to assist the development of selective PARP14 inhibitors.
| Original language | English |
|---|---|
| Pages (from-to) | 1657-1667 |
| Number of pages | 11 |
| Journal | Future Medicinal Chemistry |
| Volume | 12 |
| Issue number | 18 |
| Early online date | 7 Sept 2020 |
| DOIs | |
| Publication status | Published - Sept 2020 |
